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Background: Our aim was to investigate elastic properties of aorta such as aortic strain, aortic distensibility and aortic stiffness, as an indicator of 
subclinical cardiovascular diseases, in non-obese, non-insulin resistant women with PCOS.
Method: Forty non-obese PCOS women and 40 age- and BMI-matched healthy women were included in this study. Serum concentrations of 
luteinizing hormone, follicle stimulating hormone, free testosterone, total testosterone, DHES sulfate, androstenedione and lipid profile were 
measured in both patient group and control group. The elastic parameters of aorta; “aortic strain”, “aortic distensibility”, “aortic diameter 
alteration”, and “aortic stiffness index” have been calculated by appropriate formulae.
Results: There was no significant difference between the mean ages of the patient group and the control group (24.8 ± 5.6 vs 23.4 ± 1.7, 
p=0.969). Body mass indexes (BMI) were also similar (25.2 ± 5.0 vs 23.7 ± 2.7, p=0.326). Aortic diameter alteration and aortic strain were 
significantly higher in the patient group, compared to the control group (3.9 ± 1.3 vs 2.6 ± 1.6 and 0.17 ± 0.7 vs 0.07 ± 0.07, respectively, 
p=0.001). Aortic distensibility was 4.6 ± 0.9 in the patient group and 3.9 ± 0.8 in the control group (p=0.002). Aortic stiffness index was 
significantly lower in the patient group, compared to the control group (9.4 ± 5.2 vs 13.2 ± 5.8, p=0.002). In the patients with PCOS, there was a 
positive correlation between androstenedione and aortic distensibility (r=0.479, p=0.002); total testosterone and aortic distensibility (r=0.593, 
p=0.001); but a negative correlation between androstenedione and aortic stiffness index (r=-0.367, p=0.020) and free androgen index (FAI) and 
aortic stiffness index (r=-0.388, p=0.013).
Conclusion: In non-obese PCOS patients, who possess similar characteristics with the control group with respect to lipid profile and insulin 
resistance, “aortic stiffness” is low and “aortic distensibility” is high. In this group of PCOS patients, the reason for increased elastic characteristics of 
aorta may be hyperandrogenemia. Hyperandrogenemia may play a role in the prevention of atherosclerosis in non-obese PCOS patients.
